In accordance with applicable privacy legislation, the company Kedrion S.p.a., controller of the data acquired via this website, hereby informs the user that said website does not use profiling cookies to send advertising messages tuned to preferences expressed when browsing the internet. This website installs third party cookies. Continuing to browse, including by scrolling down and clicking on website elements, equates to consent.
For more information, also as regards the technical cookies used by the website and to refuse consent to the installation of individual cookies, please refer to the complete cookies disclosure.
You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
HIGHLIGHTS
EVENTS
Kedrion Biopharma celebrates Primary Immunodeficiency Week
The company stands alongside PI patients associations around the globe
read moreEVENTS
Kedrion Biopharma celebrates World Hemophilia Day 2018
Support for patients with coagulation disorders worldwide is confirmed
read moreEVENTS
50-Year Anniversary of a Maternal Health Breakthrough
Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai
read more-
EVENTS - 27-04-2017
Kedrion Biopharma joins IPOPI in celebrating World PI Week 2017
Global campaign to improve early diagnosis and optimal treatments for PID
read more -
CORPORATE - 19-04-2017
Kedrion Biopharma signs agreement with European Hemophilia Consortium (EHC)
The agreement aims to improve patient access to coagulation disorders treatments in Europe
read more -
EVENTS - 14-04-2017
Kedrion Biopharma initiatives for World Hemophilia Day 2017
The goal is to provide wider access to plasma-derived therapies for coagulation disorders the world over
read more -
CORPORATE - 24-03-2017
New company AO Kirov Plasma established in Russia
It’s a joint venture between Kedrion Biopharma, Nacimbio and Pharmastandard
read more
Pages
For more information please contact: pressoffice@kedrion.com
Where 